she/her
Maggie Jo Buchanan is the senior director and senior legal fellow for the Women’s Initiative at American Progress, where she leads interdisciplinary work on women’s economic security, health, and leadership.
Before her current role, Buchanan was the director of Courts and Legal Policy at American Progress, publishing widely cited reports on topics such as professional diversity on the federal bench and U.S. Supreme Court term limits. In addition, she previously served as an associate director for the Women’s Initiative, focused on women’s health and reproductive rights.
In addition to her work at American Progress, Buchanan has led policy initiatives at organizations such as Young Invincibles and NARAL Pro-Choice America. She also served as a senior legislative assistant to Rep. Lloyd Doggett (D-TX). In that role, she managed significant portions of the congressman’s Ways and Means portfolio, including his work on health care, worker and family supports, and Social Security matters. Buchanan also has significant experience in the states, working in Texas on issues that include maternal health, reproductive rights, and the unique challenges facing student-parents.
Buchanan’s work has received extensive news coverage in NPR, PBS NewsHour, Bloomberg, The Guardian, the Houston Chronicle, The Texas Tribune, The Washington Post, Politico, and more. She earned her law degree from the University of Texas School of Law and her bachelor’s degree from the University of North Carolina at Chapel Hill.
Please join the Center for American Progress to discuss the multitude of issues faced by older women and to explore solutions to improve their lives.
Media reports that Justice Clarence Thomas accepted lavish yacht trips and private jet rides without publicly disclosing them underscore the urgent need for Supreme Court justices to be bound by a binding code of ethics just like other federal judges and members of Congress.
El acceso al aborto con medicamentos es un componente vital de la salud reproductiva.
Access to medication abortion with mifepristone is a vital component of reproductive health care.
The question of abortion access will once again be considered by the Supreme Court after a series of lower court rulings that disregarded scientific and medical expertise.
By moving to halt FDA approval of mifepristone, a judge in Texas takes aim at abortion access; upends the process for drug approvals; and undermines the legitimacy of the federal judiciary.
Please join the Center for American Progress for a virtual panel discussion on the importance of medication abortion and taking politics out of drug safety.
Maggie Jo Buchanan addresses the dangerous impacts the decision in Alliance of Hippocratic Medicine v. U.S. Food and Drug Administration could have on drug safety in the United States.
The Center for American Progress recently hosted a roundtable of more than 20 advocates from the reproductive and disability rights and justice communities—and has compiled the top five policy priorities important to focus on this year.
The U.S. Food and Drug Administration’s new guidance on medication abortion has the potential to increase access to care, though challenges remain.
Pregnancy carries risks, including death. Without abortion access, more women will die.
Graham’s proposed national ban would prohibit abortion after 15 weeks nationwide, with only very narrow exceptions—while still allowing states to ban abortion even more strictly.
